PSNL logo

Personalis Inc. (PSNL)

$16

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on PSNL

Market cap

$1.71B

EPS

-1.09

P/E ratio

--

Price to sales

24.53

Dividend yield

--

Beta

2.322051

Price on PSNL

Previous close

$15.98

Today's open

$15.93

Day's range

$15.86 - $16.11

52 week range

$4.96 - $18.89

Profile about PSNL

CEO

Christopher Hall

Employees

229

Headquarters

Fremont, CA

Exchange

NASDAQ Global Market

Shares outstanding

106799872

Issue type

Common Stock

PSNL industries and sectors

Healthcare

Medical Diagnostics & Screening

News on PSNL

PSNL Merger Notice: BFA Law Notifies Personalis Shareholders of the Ongoing Investigation into the $16.25 per Share Merger

BFA Law is investigating the announced $16.25 per share merger in which Tempus AI, Inc., a commercial associate of Personalis, is set to acquire all outstanding Personalis stock; current stockholders are notified to contact the firm. New York, New York--(Newsfile Corp. - October 29, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc. Personalis is incorporated in Delaware.

news source

Newsfile Corp • 14 hours ago

news preview

$PSNL Stock Market Alert: Personalis' $16.25 per Share Merger Is Under Investigation – Contact BFA Law if You Are a Shareholder

NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc.   Personalis is incorporated in Delaware. If you are a current stockholder of Personalis, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/personalis-merger-investigation.

news source

GlobeNewsWire • Oct 28, 2026

news preview

PSNL Investor Investigation: Personalis Shareholders Are Alerted to the Pending Investigation into the $16.25 per Share Merger

BFA Law is investigating the announced $16.25 per share merger in which Tempus AI, Inc., a commercial associate of Personalis, is set to acquire all outstanding Personalis stock; current stockholders are notified to contact the firm. NEW YORK, Oct. 27, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP  announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc.  Personalis is incorporated in Delaware.

news source

PRNewsWire • Oct 27, 2026

news preview

$PSNL Merger Investigation: BFA Law Reminds Personalis Shareholders of Its Ongoing Investigation into the $16.25 per Share Merger Deal

NEW YORK, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc.   Personalis is incorporated in Delaware. If you are a current stockholder of Personalis, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/personalis-merger-investigation.

news source

GlobeNewsWire • Oct 26, 2026

news preview

PERSONALIS, INC. INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Personalis, Inc.'s Directors and Officers for Breach of Fiduciary Duties – PSNL

Scott+Scott Attorneys at Law LLP is investigating whether the directors of Personalis, Inc. breached their fiduciary duties to Personalis's shareholders.

news source

GlobeNewsWire • Oct 26, 2026

news preview

Investor Notification: Personalis, Inc. ($PSNL) Investors Are Reminded to Contact BFA Law About the Ongoing Investigation into $16.25 per Share Merger Deal

BFA Law is investigating the announced $16.25 per share merger in which Tempus AI, Inc., a commercial associate of Personalis, is set to acquire all outstanding Personalis stock; current stockholders are notified to contact the firm. New York, New York--(Newsfile Corp. - October 24, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc. Personalis is incorporated in Delaware.

news source

Newsfile Corp • Oct 24, 2026

news preview

PSNL Investigation News: Personalis, Inc. Investors are Notified of the Pending Investigation into Ongoing Merger – Contact BFA Law if You Hold Shares

NEW YORK, Oct. 23, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc.   Personalis is incorporated in Delaware. If you are a current stockholder of Personalis, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/personalis-merger-investigation.

news source

GlobeNewsWire • Oct 23, 2026

news preview

PSNL Securities Notice: Personalis, Inc. Shareholders Are Notified to Contact BFA Law About Its Pending Investigation into the $16.25 per Share Merger Deal

BFA Law is investigating the announced $16.25 per share merger in which Tempus AI, Inc., a commercial associate of Personalis, is set to acquire all outstanding Personalis stock; current stockholders are notified to contact the firm. New York, New York--(Newsfile Corp. - October 22, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Personalis, Inc. (NASDAQ: PSNL) is being taken private by Tempus AI, Inc. Personalis is incorporated in Delaware.

news source

Newsfile Corp • Oct 22, 2026

news preview

PSNL Stock Notification: Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law

NEW YORK--(BUSINESS WIRE)---- $PSNL #Acquisition--Personalis, Inc. is being Investigated after the $16.25 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law.

news source

Business Wire • Oct 21, 2026

news preview

Personalis NeXT Personal® Data Showcasing Ultrasensitive MRD to be Presented at ESMO 2026

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that two oral presentations and two poster presentations featuring its NeXT Personal ultrasensitive circulating tumor DNA (ctDNA) test will be presented at the European Society for Medical Oncology (ESMO) Congress 2026, taking place October 23-27 in Madrid, Spain. Highlights include a late-breaking oral presentation of NeXT Personal data for the C-POST Phase 3.

news source

Business Wire • Oct 21, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Personalis Inc.

Open an M1 investment account to buy and sell Personalis Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in PSNL on M1